The Nutshell

» NIH and cancer

Daily News Roundup

Most Recent

image: Obama’s Budget Seeks Science Boost

Obama’s Budget Seeks Science Boost

By | February 2, 2015

Fiscal year 2016 could be very bright for the research enterprise if the President’s budgetary requests are granted.

1 Comment

image: Roche Snags Tumor Tester for $1B

Roche Snags Tumor Tester for $1B

By | January 13, 2015

The pharmaceutical company bought a majority stake in Foundation Medicine, a firm that develops personalized cancer-medicine diagnostics.

0 Comments

image: Funding Turnaround?

Funding Turnaround?

By | January 12, 2015

The National Institutes of Health saw a slight improvement in success rate for R01 or equivalent grants last year.

3 Comments

image: Trainee Raise

Trainee Raise

By | January 12, 2015

Grad students and postdoctoral fellows supported by US National Institutes of Health National Research Service Awards land a 2 percent stipend bump in 2015.

2 Comments

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

1 Comment

image: “Father of Modern Hematology” Dies

“Father of Modern Hematology” Dies

By | December 17, 2014

Australian researcher Donald Metcalf, whose discoveries transformed cancer treatment, has passed away at age 85.

0 Comments

image: NIH Study Canceled

NIH Study Canceled

By | December 15, 2014

The National Institutes of Health shutters its initiative to track the health of 100,000 children through adulthood.

3 Comments

image: 2015 Science Funding Flat

2015 Science Funding Flat

By | December 15, 2014

The US legislature passed a spending agreement for next year, and the deal has only modest increases for federal science agencies.

0 Comments

image: Ebola Update

Ebola Update

By | December 11, 2014

NIH admits new patient; joint pains stall clinical trial; U.S. grants immunity to vaccine developers; more

1 Comment

image: Ebola Vaccine Candidate Shows Promise

Ebola Vaccine Candidate Shows Promise

By | December 1, 2014

An experimental Ebola vaccine developed by the US National Institutes of Health appears to be safe and effective, according to a small, early-stage clinical trial.

0 Comments

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  3. Most of Human Genome Nonfunctional: Study
  4. Identifying Predatory Publishers
AAAS